OP 21
Alternative Names: Breast cancer therapy - San Diego Research; OP21Latest Information Update: 03 Apr 2003
At a glance
- Originator San Diego Research
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Breast cancer
Most Recent Events
- 03 Apr 2003 No development reported - Preclinical for Breast cancer in USA (unspecified route)
- 07 May 2001 New profile
- 07 May 2001 OP 21 is available for licensing